101 related articles for article (PubMed ID: 10645028)
1. Update on gene therapy for intimal hyperplasia.
Reis ED; Skladany M
Bratisl Lek Listy; 1999 Aug; 100(8):417-21. PubMed ID: 10645028
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of intimal hyperplasia by gene therapy: an update].
Reis E; Martinet O; Mosimann F
J Mal Vasc; 1999 Dec; 24(5):349-55. PubMed ID: 10642646
[TBL] [Abstract][Full Text] [Related]
3. Potent inhibition of arterial intimal hyperplasia by TIMP1 gene transfer using AAV vectors.
Ramirez Correa GA; Zacchigna S; Arsic N; Zentilin L; Salvi A; Sinagra G; Giacca M
Mol Ther; 2004 Jun; 9(6):876-84. PubMed ID: 15194054
[TBL] [Abstract][Full Text] [Related]
4. Fas ligand gene therapy for vascular intimal hyperplasia.
Jiang C; Yang YF; Cheng SH
Curr Gene Ther; 2004 Mar; 4(1):33-9. PubMed ID: 15032612
[TBL] [Abstract][Full Text] [Related]
5. Local administration of NF-kappa B decoy oligonucleotides to prevent restenosis after balloon angioplasty: an experimental study in New Zealand white rabbits.
Kalinowski M; Viehofer K; Hamann C; Barry JJ; Kleb B; Klose KJ; Wagner HJ; Alfke H
Cardiovasc Intervent Radiol; 2005; 28(3):331-7. PubMed ID: 15886949
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a new double-injury restenosis model in the rat aorta.
Jahnke T; Karbe U; Schäfer FK; Bolte H; Heuer G; Rector L; Brossmann J; Heller M; Müller-Hülsbeck S
J Endovasc Ther; 2005 Jun; 12(3):318-31. PubMed ID: 15943507
[TBL] [Abstract][Full Text] [Related]
7. Glucagon-Like Peptide-1 Receptor Activation Does not Affect Re-Endothelialization but Reduces Intimal Hyperplasia via Direct Effects on Smooth Muscle Cells in a Nondiabetic Model of Arterial Injury.
Eriksson L; Saxelin R; Röhl S; Roy J; Caidahl K; Nyström T; Hedin U; Razuvaev A
J Vasc Res; 2015; 52(1):41-52. PubMed ID: 25966620
[TBL] [Abstract][Full Text] [Related]
8. The cyclolignan picropodophyllin attenuates intimal hyperplasia after rat carotid balloon injury by blocking insulin-like growth factor-1 receptor signaling.
Razuvaev A; Henderson B; Girnita L; Larsson O; Axelson M; Hedin U; Roy J
J Vasc Surg; 2007 Jul; 46(1):108-15. PubMed ID: 17606126
[TBL] [Abstract][Full Text] [Related]
9. Gene therapy of fibroproliferative vasculopathies: current ideas in molecular mechanisms and biomedical technology.
Mitra AK; Agrawal DK
Pharmacogenomics; 2006 Dec; 7(8):1185-98. PubMed ID: 17184206
[TBL] [Abstract][Full Text] [Related]
10. CD4+ mononuclear cells induce cytokine expression, vascular smooth muscle cell proliferation, and arterial occlusion after endothelial injury.
Hancock WW; Adams DH; Wyner LR; Sayegh MH; Karnovsky MJ
Am J Pathol; 1994 Nov; 145(5):1008-14. PubMed ID: 7977633
[TBL] [Abstract][Full Text] [Related]
11. Preclinical evaluation of inducible nitric oxide synthase lipoplex gene therapy for inhibition of stent-induced vascular neointimal lesion formation.
Muhs A; Heublein B; Schletter J; Herrmann A; Rüdiger M; Sturm M; Grust A; Malms J; Schrader J; von der Leyen HE
Hum Gene Ther; 2003 Mar; 14(4):375-83. PubMed ID: 12659678
[TBL] [Abstract][Full Text] [Related]
12. [Hyperplasia of the arterial intima due to smooth muscle cell proliferation. Current data, experimental treatments and perspectives].
Ducasse E; Cosset JM; Eschwège F; Chevalier J; De Ravignan D; Puppinck P; Lartigau E
J Mal Vasc; 2003 Jun; 28(3):130-44. PubMed ID: 12910189
[TBL] [Abstract][Full Text] [Related]
13. Irradiation for the treatment of intimal hyperplasia.
Fortunato JE; Glagov S; Bassiouny HS
Ann Vasc Surg; 1998 Sep; 12(5):495-503. PubMed ID: 9732431
[TBL] [Abstract][Full Text] [Related]
14. Role of Galphaq in smooth muscle cell proliferation.
Tanski WJ; Roztocil E; Hemady EA; Williams JA; Davies MG
J Vasc Surg; 2004 Mar; 39(3):639-44. PubMed ID: 14981460
[TBL] [Abstract][Full Text] [Related]
15. Endoluminal smooth muscle cell seeding limits intimal hyperplasia.
Gomes D; Louedec L; Plissonnier D; Dauge MC; Henin D; Osborne-Pellegrin M; Michel JB
J Vasc Surg; 2001 Oct; 34(4):707-15. PubMed ID: 11668328
[TBL] [Abstract][Full Text] [Related]
16. G-protein expression and intimal hyperplasia after arterial injury: a role for Galpha(i) proteins.
Davies MG; Mason DP; Tran PK; Deou J; Hawkins S; Clowes AW
J Vasc Surg; 2001 Feb; 33(2):408-18. PubMed ID: 11174797
[TBL] [Abstract][Full Text] [Related]
17. The god of small things: the biology of intimal hyperplasia.
Williams D
Med Device Technol; 1999 Oct; 10(8):8-11. PubMed ID: 10724779
[TBL] [Abstract][Full Text] [Related]
18. Dominant negative c-jun gene transfer inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia in rats.
Yasumoto H; Kim S; Zhan Y; Miyazaki H; Hoshiga M; Kaneda Y; Morishita R; Iwao H
Gene Ther; 2001 Nov; 8(22):1682-9. PubMed ID: 11892835
[TBL] [Abstract][Full Text] [Related]
19. Blockade of vascular smooth muscle cell proliferation and intimal thickening after balloon injury by the sulfated oligosaccharide PI-88: phosphomannopentaose sulfate directly binds FGF-2, blocks cellular signaling, and inhibits proliferation.
Francis DJ; Parish CR; McGarry M; Santiago FS; Lowe HC; Brown KJ; Bingley JA; Hayward IP; Cowden WB; Campbell JH; Campbell GR; Chesterman CN; Khachigian LM
Circ Res; 2003 May; 92(8):e70-7. PubMed ID: 12690039
[TBL] [Abstract][Full Text] [Related]
20. Increased vascular injury reduces the degree of intimal hyperplasia following angioplasty in rabbits.
Fogelstrand P; Mellander S; Mattsson E
J Vasc Res; 2011; 48(4):307-15. PubMed ID: 21273785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
